ArticleFrontiers in oncology2022

Serum cytokines predict efficacy and toxicity, but are not useful for disease monitoring in lung cancer treated with PD-(L)1 inhibitors.

Hannah Schindler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.